Search research articles
Contact Us
Filters
Showing results (71-80 of 87) with videos related to
Page
of 9
Sort By:
Leukemia
|
September 23, 2022
Activity of menin inhibitor ziftomenib (KO-539) as monotherapy or in combinations against AML cells with MLL1 rearrangement or mutant NPM1
Warren Fiskus, Naval Daver, Steffen Boettcher, et al.
Blood Cancer Journal
|
January 12, 2022
Effective Menin inhibitor-based combinations against AML with MLL rearrangement or NPM1 mutation (NPM1c)
Warren Fiskus, Steffen Boettcher, Naval Daver, et al.
Leukemia
|
December 19, 2025
BET inhibitor-based combinations targeting novel dependencies in MECOM-rearranged (r) AML
Christine E Birdwell, Warren Fiskus, Christopher P Mill, et al.
Blood
|
October 3, 2021
Effective therapy for AML with RUNX1 mutation by cotreatment with inhibitors of protein translation and BCL2
Christopher P Mill, Warren Fiskus, Courtney D DiNardo, et al.
Leukemia
|
March 12, 2026
Correction: BET inhibitor-based combinations targeting novel dependencies in MECOM-rearranged (r) AML
Christine E Birdwell, Warren Fiskus, Christopher P Mill, et al.
Leukemia
|
December 12, 2023
Preclinical efficacy of targeting epigenetic mechanisms in AML with 3q26 lesions and EVI1 overexpression
Christine E Birdwell, Warren Fiskus, Tapan M Kadia, et al.
Blood Cancer Journal
|
April 13, 2023
Targeting of epigenetic co-dependencies enhances anti-AML efficacy of Menin inhibitor in AML with MLL1-r or mutant NPM1
Warren Fiskus, Christopher P Mill, Christine Birdwell, et al.
Annals of Global Health
|
January 12, 2026
Pathways to Clinical Training Opportunities for International Medical Students and IMGs: The California Experience
Margaret Akey, Brian Groves, James C Hudspeth, et al.
BMC Medical Education
|
May 1, 2024
Sexual and gender minority content in undergraduate medical education in the United States and Canada: current state and changes since 2011
Carl G Streed, Amy Michals, Emily Quinn, et al.
Leukemia
|
March 3, 2021
BET proteolysis targeted chimera-based therapy of novel models of Richter Transformation-diffuse large B-cell lymphoma
Warren Fiskus, Christopher P Mill, Dimuthu Perera, et al.
Page
of 9
Search research articles
Search
Showing results (71-80 of 87) with videos related to
Sort By:
Page
of 9
Leukemia
|
September 23, 2022
Activity of menin inhibitor ziftomenib (KO-539) as monotherapy or in combinations against AML cells with MLL1 rearrangement or mutant NPM1
Warren Fiskus, Naval Daver, Steffen Boettcher, et al.
Blood Cancer Journal
|
January 12, 2022
Effective Menin inhibitor-based combinations against AML with MLL rearrangement or NPM1 mutation (NPM1c)
Warren Fiskus, Steffen Boettcher, Naval Daver, et al.
Leukemia
|
December 19, 2025
BET inhibitor-based combinations targeting novel dependencies in MECOM-rearranged (r) AML
Christine E Birdwell, Warren Fiskus, Christopher P Mill, et al.
Blood
|
October 3, 2021
Effective therapy for AML with RUNX1 mutation by cotreatment with inhibitors of protein translation and BCL2
Christopher P Mill, Warren Fiskus, Courtney D DiNardo, et al.
Leukemia
|
March 12, 2026
Correction: BET inhibitor-based combinations targeting novel dependencies in MECOM-rearranged (r) AML
Christine E Birdwell, Warren Fiskus, Christopher P Mill, et al.
Leukemia
|
December 12, 2023
Preclinical efficacy of targeting epigenetic mechanisms in AML with 3q26 lesions and EVI1 overexpression
Christine E Birdwell, Warren Fiskus, Tapan M Kadia, et al.
Blood Cancer Journal
|
April 13, 2023
Targeting of epigenetic co-dependencies enhances anti-AML efficacy of Menin inhibitor in AML with MLL1-r or mutant NPM1
Warren Fiskus, Christopher P Mill, Christine Birdwell, et al.
Annals of Global Health
|
January 12, 2026
Pathways to Clinical Training Opportunities for International Medical Students and IMGs: The California Experience
Margaret Akey, Brian Groves, James C Hudspeth, et al.
BMC Medical Education
|
May 1, 2024
Sexual and gender minority content in undergraduate medical education in the United States and Canada: current state and changes since 2011
Carl G Streed, Amy Michals, Emily Quinn, et al.
Leukemia
|
March 3, 2021
BET proteolysis targeted chimera-based therapy of novel models of Richter Transformation-diffuse large B-cell lymphoma
Warren Fiskus, Christopher P Mill, Dimuthu Perera, et al.
Page
of 9